Ibrutinib-MPEA
Modify Date: 2025-08-21 17:20:40
Ibrutinib-MPEA structure
|
Common Name | Ibrutinib-MPEA | ||
|---|---|---|---|---|
| CAS Number | 1710768-30-1 | Molecular Weight | 581.71 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C32H39N9O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Ibrutinib-MPEAIbrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies[1]. |
| Name | Ibrutinib-MPEA |
|---|
| Description | Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C32H39N9O2 |
|---|---|
| Molecular Weight | 581.71 |